Clinical Trials Directory

An Open-label, Multi-center, Phase 2 Study of Denosumab in Subjects With Giant Cell Tumor of Bone

To determine how safe denosumab is in treating subjects with giant cell tumor of bone

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.



  • drug : Denosumab

Phase: Phase 2


Ages Eligible For Study:

12 Years - N/A

External Links

Explore related trials

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Cancer clinical Trials Office
Not Recruiting

Footer Links: